Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Blood Specimen Collection × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 103 Neoplasms 8 Lung Neoplasms 7 Triple Negative Breast Neoplasms 6 Neoplastic Cells, Circulating 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Recurrence 3 Prostatic Neoplasms 3 Hodgkin Disease 3 Hereditary Breast and Ovarian Cancer Syndrome 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Obesity 2 Melanoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Fibrosis 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Seroma 1 Sarcoma, Ewing 1 Sarcoma 1 Renal Insufficiency 1 Rectal Neoplasms 1

Interventions

palbociclib 6 Letrozole 6 Docetaxel 6 Anastrozole 6 exemestane 5 Trastuzumab 5 Fulvestrant 5 ribociclib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 pyrotinib 3 Doxorubicin 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Capecitabine 2 Botulinum Toxins, Type A 2 AZD9833 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00842465 2013-11-25

Prolacsein

Assistance Publique - Hôpitaux de Paris

Breast Diseases, Breast Neoplasms, Cystic Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡